Dublin, May 28, 2019 (GLOBE NEWSWIRE) -- The "France In-Vitro Diagnostics (IVD) Market by Segments, Types (Laboratory Reagents, Instruments), & Companies" report has been added to ResearchAndMarkets.com's offering.

France In Vitro Diagnostics market is expected to be around US$ 5 Billion by the end of the year 2024.

In Vitro Diagnostic services are done either through imaging like scanning, radiology, and ultrasound or in laboratories via pathology, IVD plays a crucial function in identifying health-related problems. In Vitro Diagnostic comes under medical device segment in France, which is utilized for disease diagnostic and medical treatment. Timely diagnosis improves the chances of positive development, thus helping in saving the costs of future treatment and improving the lives of patients. Moreover In Vitro Diagnostics also plays an important part in ongoing care program for patients.

Currently, the United States dominates the In Vitro Diagnostics market followed by Europe. This particular trend is also expected to continue in the future. Growth in the number of an aging population has become one of the important drivers for the In vitro diagnostics market in France.

In 1991, EU-28's population, of persons aged 65and over was 13.9% and this figure further increased to 18.5% by the end of the year 2014. In Europe, most medical technologies are reimbursed by Public Health Authorities, generally within a third-party payer system. However, each European country has its own special nature; in a few European countries reimbursement and budgeting is decided at the regional level, whereas in some countries it is decided by the national government of that country.

Market Dynamics

Growth Drivers

• Increase in the Cancer Disease Population
• Technological Advances
• Rapidly Aging Population

Challenges

• Cumbersome Reimbursement Procedure

Laboratory reagents are the leading products in the France In-Vitro Diagnostics (IVD) Market

In this report, we have done a comprehensive analysis of France In-Vitro Diagnostics (IVD) market by products. It includes laboratory reagents and instruments market. The laboratory reagent is the leading segment in the France In-Vitro Diagnostics (IVD) market.

Immunochemistry dominates the France IVD Market

France In-Vitro Diagnostics (IVD) Market is segmented into immunochemistry, hematology, infectious immunology, microbiology, bio-chemistry, and genetic testing. Immunochemistry has the highest market in the France IVD segment.

Company Analysis

Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies in the France In-Vitro Diagnostics (IVD) Market. All the companies have been studied from three points.

• Overview
• Initiatives & Recent Developments
• Sales

By Types - France In-Vitro Diagnostics (IVD) Market

• Laboratory Reagents
• Instruments

By Segments - France In-Vitro Diagnostics (IVD) Market

• Immunochemistry
• Hematology
• Infectious Immunology
• Microbiology
• Bio-chemistry
• Genetic Testing

Companies covered in this report

• Roche Diagnostics
• Abbott Diagnostics
• Siemens Healthineers
• Danaher Corporation
• Thermo Fisher Scientific
• Sysmex Corporation

For more information about this report visit https://www.researchandmarkets.com/r/cfmdsx

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics, Laboratory Testing

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.